|
"Big Four" Pharmaceutical Pricing Boot CampIntensive training in the essential pricing concepts and methodologies related to VA, DoD, PHS, and Coast Guard programsMonday, May 21, 2007
AboutLearn to work effectively and efficiently with the largest purchaser of pharmaceutical products The U.S. government spends billions of dollars per year on the purchase of drugs, making it the largest purchaser of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company’s total revenue, and a company cannot remain competitive in today’s market without selling to the government. As pharmaceutical manufacturers’ revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs. While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of “Big Four” pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned contracting practitioner baffled. On top of complying with the “Big Four’s” numerous rules and regulations, companies must also evaluate how their “Big Four” prices affect their overall pricing. Master the essentials of key “Big Four” pricing concepts and methodologies This publication from ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies. ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies. Contents & ContributorsAboutLearn to work effectively and efficiently with the largest purchaser of pharmaceutical products The U.S. government spends billions of dollars per year on the purchase of drugs, making it the largest purchaser of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company’s total revenue, and a company cannot remain competitive in today’s market without selling to the government. As pharmaceutical manufacturers’ revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs. While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of “Big Four” pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned contracting practitioner baffled. On top of complying with the “Big Four’s” numerous rules and regulations, companies must also evaluate how their “Big Four” prices affect their overall pricing. Master the essentials of key “Big Four” pricing concepts and methodologies This publication from ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies. ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies. Contents & ContributorsKNOWING YOUR CUSTOMER: OVERVIEW OF THE “BIG FOUR” AND THEIR PHARMACEUTICAL RELATED PROGRAMSDavid C. Hammond, Crowell & Moring LLP ESTABLISHING THE FEDERAL CEILING PRICE (FCP) Joy E. Sturm, Hogan & Hartson LLP Marci Anderson, VA Office of Inspector General Melbourne A. Noel, Jr., Department of Veteran Affairs John D. Shakow, King & Spalding FSS CONTRACTING FOR THE PHARMACEUTICAL INDUSTRY Melbourne A. Noel, Jr., Department of Veteran Affairs EFFECTIVELY MANAGING NEGOTIATIONS WITH V.A. William W. Goodrich, Jr., Arent Fox LLP DISCLOSURES AND NEGOTIATIONS: WHAT VA EXPECTS Maureen Regan, VA Office of Inspector General PRICE ADJUSTMENT CLAUSE AND PRICE REDUCTION CLAUSE Stephen E. Ruscus, McKenna Long & Aldridge PRICE ADJUSTMENT AND PRICE REDUCTION CLAUSES: VA’S PERSPECTIVE Maureen Regan, VA Office of Inspector General VA PHARMACY BENEFITS MANAGEMENT STRATEGIC HEALTHCARE GROUP UPDATE Joseph J. Canzolino, R.PH. , Pharmacy Benefits Managements Strategic Healthcare Group DEMYSTIFYING THE DOD UNIFORM FORMULARY Allison D. Pugsley, Esq., Hogan & Hartson LLP STRATEGIES FOR SECURING NATIONAL CONTRACTS David C. Hammond, Crowell & Moring LLP TRICARE: A STUDY IN THE DOD’S MANAGED HEALTH CARE BENEFITS PROGRAM Joy E. Sturm, Hogan & Hartson LLP Melbourne A. Noel, Jr., Department of Veteran Affairs Howard R. Altschwager, TRICARE Management Activity BASICS OF PHS 340B DRUG DISCOUNT PROGRAM Edward J. McAdam, Sr., Daiichi Sankyo, Inc. William von Oehsen, Powers Pyles Sutter & Vervile PC OVERVIEW OF THE DEPARTMENT OF DEFENSE (DOD) PHARMACY PROGRAM Howard R. Altschwager, TRICARE Management Activity TRICARE RETAIL PHARMACY PROGRAM: EVOLUTION OF THE RETAIL REBATE Joy E. Sturm, Hogan & Hartson LLP PROPOSED RULE PUBLISHED FOR PUBLIC COMMENT IN 70 FEDERAL REGISTER, PAGE 19045, APRIL 12, 2005 Melbourne A. Noel, Jr., Department of Veteran Affairs AUDIT RIGHTS, RECORD RETENTION AND PENALTIES William W. Goodrich, Arent Fox LLP AUDIT RIGHTS, RECORD RETNETION AND PENALTIES Maureen Regan, VA Office of Inspector General ENFORCEMENT LANDSCAPE IN PHARMACEUTICAL GOVERNMENT CONTRACTING Elizabeth I. Hack, McDermott Will & Emery THE MEDICAID/340B PROGRAM “BEST PRICE” ENFORCEMENT LANDSCAPE Kirsten Mayer, Ropes & Gray LLP |
Date: Mon, May 21, 2007 Location:
New York, NY Pricing:
Option 1: Bundle Package
Binder & CD-ROM Save 299 - Best Value! Total: $699 + $9.95 (shipping & handling) + applicable taxes Option 2: CD-ROM
CD-ROM of program proceedings Total: $499 + $9.95 (shipping & handling) + applicable taxes Option 3: Binder
Printed copy of program proceedings Total: $499 + $9.95 (shipping & handling) |
 |
Publication Details |
Copyright 2007 C5 Group Inc. All Rights Reserved. |